Sign In
to Vote &
Create Storyboards.
 
New antiviral pill halves risk of COVID-19 hospitalization, Merck says Merck announced promising trial results this week, but the full data has yet to be released.
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard